CDK9 and P-TEFb have also emerged as candidate targets in cancer and leukemia because of their critical role in regulating gene expression [30], and it has been suggested that CDK9 also reactivates tumor suppressor genes and is involved in promoting and maintaining cancer cell growth [30]. The gene discussed is CDK9; the disease is leukemia.